Tasly Pharmaceutical Group Co Ltd (600535) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.044x

Based on the latest financial reports, Tasly Pharmaceutical Group Co Ltd (600535) has a cash flow conversion efficiency ratio of 0.044x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥552.13 Million ≈ $80.79 Million USD) by net assets (CN¥12.55 Billion ≈ $1.84 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Tasly Pharmaceutical Group Co Ltd balance sheet independence to measure how much of total assets are equity-financed.

Tasly Pharmaceutical Group Co Ltd - Cash Flow Conversion Efficiency Trend (2001–2025)

This chart illustrates how Tasly Pharmaceutical Group Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check how high is Tasly Pharmaceutical Group Co Ltd's earnings quality to evaluate the quality of earnings relative to operating cash generation.

Tasly Pharmaceutical Group Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Tasly Pharmaceutical Group Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Tango Therapeutics Inc NASDAQ:TNGX	-0.086x
Qingdao East Steel Tower Stock Co Ltd SHE:002545	0.055x
China Zhenhua Group Science & Technology Co Ltd SHE:000733	-0.018x
Bilfinger SE XETRA:GBF	0.082x
Avient Corp NYSE:AVNT	-0.014x
AllianceBernstein Holding L.P. NYSE:AB	0.061x
GZ Port SHG:601228	0.010x
Sai MicroElectronics Inc SHE:300456	-0.006x

Annual Cash Flow Conversion Efficiency for Tasly Pharmaceutical Group Co Ltd (2001–2025)

The table below shows the annual cash flow conversion efficiency of Tasly Pharmaceutical Group Co Ltd from 2001 to 2025. For the full company profile with market capitalisation and key ratios, see 600535 company net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥12.55 Billion ≈ $1.84 Billion	CN¥1.42 Billion ≈ $208.49 Million	0.114x	-31.74%
2024-12-31	CN¥12.11 Billion ≈ $1.77 Billion	CN¥2.01 Billion ≈ $294.79 Million	0.166x	-18.05%
2023-12-31	CN¥12.69 Billion ≈ $1.86 Billion	CN¥2.58 Billion ≈ $376.90 Million	0.203x	+12.19%
2022-12-31	CN¥12.63 Billion ≈ $1.85 Billion	CN¥2.29 Billion ≈ $334.39 Million	0.181x	-14.01%
2021-12-31	CN¥13.31 Billion ≈ $1.95 Billion	CN¥2.80 Billion ≈ $409.90 Million	0.210x	+45.47%
2020-12-31	CN¥12.38 Billion ≈ $1.81 Billion	CN¥1.79 Billion ≈ $262.10 Million	0.145x	+2.12%
2019-12-31	CN¥11.86 Billion ≈ $1.74 Billion	CN¥1.68 Billion ≈ $245.86 Million	0.142x	+6.27%
2018-12-31	CN¥11.21 Billion ≈ $1.64 Billion	CN¥1.49 Billion ≈ $218.59 Million	0.133x	+245.41%
2017-12-31	CN¥8.97 Billion ≈ $1.31 Billion	CN¥-822.56 Million ≈ $-120.37 Million	-0.092x	-165.20%
2016-12-31	CN¥8.21 Billion ≈ $1.20 Billion	CN¥1.15 Billion ≈ $168.83 Million	0.141x	+218.67%
2015-12-31	CN¥7.71 Billion ≈ $1.13 Billion	CN¥340.00 Million ≈ $49.75 Million	0.044x	-63.75%
2014-12-31	CN¥5.07 Billion ≈ $741.67 Million	CN¥616.76 Million ≈ $90.25 Million	0.122x	+45.65%
2013-12-31	CN¥4.14 Billion ≈ $606.32 Million	CN¥346.17 Million ≈ $50.66 Million	0.084x	-14.97%
2012-12-31	CN¥4.21 Billion ≈ $615.55 Million	CN¥413.31 Million ≈ $60.48 Million	0.098x	+174.55%
2011-12-31	CN¥3.78 Billion ≈ $552.55 Million	CN¥135.14 Million ≈ $19.77 Million	0.036x	-68.97%
2010-12-31	CN¥3.42 Billion ≈ $501.18 Million	CN¥395.05 Million ≈ $57.81 Million	0.115x	-37.45%
2009-12-31	CN¥2.17 Billion ≈ $317.70 Million	CN¥400.39 Million ≈ $58.59 Million	0.184x	+48.33%
2008-12-31	CN¥2.09 Billion ≈ $306.26 Million	CN¥260.21 Million ≈ $38.08 Million	0.124x	+10.81%
2007-12-31	CN¥1.97 Billion ≈ $288.96 Million	CN¥221.55 Million ≈ $32.42 Million	0.112x	+37.29%
2006-12-31	CN¥1.72 Billion ≈ $251.70 Million	CN¥140.56 Million ≈ $20.57 Million	0.082x	-40.49%
2005-12-31	CN¥1.56 Billion ≈ $229.00 Million	CN¥214.90 Million ≈ $31.45 Million	0.137x	-7.13%
2004-12-31	CN¥1.37 Billion ≈ $201.15 Million	CN¥203.27 Million ≈ $29.74 Million	0.148x	+201.11%
2003-12-31	CN¥1.20 Billion ≈ $175.82 Million	CN¥59.00 Million ≈ $8.63 Million	0.049x	-76.26%
2002-12-31	CN¥997.00 Million ≈ $145.89 Million	CN¥206.22 Million ≈ $30.18 Million	0.207x	-38.96%
2001-12-31	CN¥247.20 Million ≈ $36.17 Million	CN¥83.77 Million ≈ $12.26 Million	0.339x	--

About Tasly Pharmaceutical Group Co Ltd

SHG:600535 China Drug Manufacturers - Specialty & Generic

Market Cap

$3.39 Billion

CN¥23.14 Billion CNY

Market Cap Rank

#4562 Global

#733 in China

Share Price

CN¥15.49

Change (1 day)

-1.46%

52-Week Range

CN¥13.23 - CN¥17.41

All Time High

CN¥29.37